The same genetic approach targeting at exon 2-4 of Uox on Sprague Dawley rats resulted in a 95% survival up to one year, but only mild hyperuricemia, suggesting different responses to Uox inactivation between animal species [8]. The gene discussed is UOX; the disease is hyperuricemia.